Variant report
Variant | nsv10240 |
---|---|
Chromosome Location | chr3:611921-663701 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:109)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr3:638972-639242 | GM12878 | blood: | n/a | chr3:639093-639102 |
2 | BRCA1 | chr3:649451-649478 | Hela-S3 | cervix: | n/a | n/a |
3 | BRCA1 | chr3:639591-639851 | Hela-S3 | cervix: | n/a | n/a |
4 | BRCA1 | chr3:638578-639330 | Hela-S3 | cervix: | n/a | n/a |
5 | CEBPB | chr3:649124-649464 | Hela-S3 | cervix: | n/a | n/a |
6 | CEBPB | chr3:650039-650244 | HepG2 | liver: | n/a | chr3:650073-650084 chr3:650075-650084 |
7 | CEBPB | chr3:638934-639824 | Hela-S3 | cervix: | n/a | n/a |
8 | CEBPB | chr3:650024-650224 | A549 | lung: | n/a | chr3:650073-650084 chr3:650075-650084 |
9 | CEBPB | chr3:649955-650248 | IMR90 | lung: | n/a | chr3:650073-650084 chr3:650075-650084 |
10 | CEBPB | chr3:637765-638119 | Hela-S3 | cervix: | n/a | n/a |
11 | CHD1 | chr3:660628-660658 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | CHD2 | chr3:639101-639345 | Hela-S3 | cervix: | n/a | n/a |
13 | CTCF | chr3:616940-617090 | HepG2 | liver: | n/a | n/a |
14 | CTCF | chr3:659480-659630 | GM12875 | blood: | n/a | n/a |
15 | CTCF | chr3:658486-658533 | A549 | lung: | n/a | n/a |
16 | CTCF | chr3:641109-641158 | ProgFib | skin: | n/a | n/a |
17 | CTCF | chr3:623741-623815 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr3:655980-656130 | GM12875 | blood: | n/a | n/a |
19 | CTCF | chr3:616960-617110 | Hela-S3 | cervix: | n/a | n/a |
20 | CTCF | chr3:618424-618441 | LNCaP | prostate: | n/a | n/a |
21 | CTCF | chr3:616980-617130 | HEK293 | kidney: | n/a | n/a |
22 | CTCF | chr3:617062-617147 | MCF-7 | breast: | n/a | n/a |
23 | CTCF | chr3:616940-617090 | A549 | lung: | n/a | n/a |
24 | CTCF | chr3:612832-612875 | ProgFib | skin: | n/a | n/a |
25 | CTCF | chr3:650545-650626 | ProgFib | skin: | n/a | n/a |
26 | CTCF | chr3:662427-662492 | GM20000 | blood: | n/a | n/a |
27 | CTCF | chr3:616998-617162 | Hela-S3 | cervix: | n/a | n/a |
28 | CTCF | chr3:615631-615719 | ProgFib | skin: | n/a | n/a |
29 | CTCF | chr3:616960-617110 | GM12870 | blood: | n/a | n/a |
30 | CTCF | chr3:616960-617110 | WERI-Rb-1 | eye: | n/a | n/a |
31 | CTCF | chr3:616960-617110 | GM12865 | blood: | n/a | n/a |
32 | CTCF | chr3:616960-617110 | SK-N-SH_RA | brain: | n/a | n/a |
33 | CTCF | chr3:612787-612876 | GM13976 | blood: | n/a | n/a |
34 | CTCF | chr3:623765-623780 | ProgFib | skin: | n/a | n/a |
35 | CTCF | chr3:658448-658477 | ProgFib | skin: | n/a | n/a |
36 | CTCF | chr3:617015-617090 | LNCaP | prostate: | n/a | n/a |
37 | CTCF | chr3:616980-617130 | HEEpiC | esophagus: | n/a | n/a |
38 | CTCF | chr3:626000-626150 | NHDF-neo | bronchial: | n/a | n/a |
39 | CTCF | chr3:616980-617130 | Caco-2 | colon: | n/a | n/a |
40 | ELK1 | chr3:639661-639775 | Hela-S3 | cervix: | n/a | n/a |
41 | ELK1 | chr3:639134-639183 | Hela-S3 | cervix: | n/a | n/a |
42 | EP300 | chr3:620995-621568 | SK-N-SH | brain: | n/a | n/a |
43 | EP300 | chr3:638941-639877 | Hela-S3 | cervix: | n/a | chr3:639272-639286 |
44 | FOS | chr3:614457-614821 | HUVEC | blood vessel: | n/a | n/a |
45 | FOXA2 | chr3:623512-623895 | A549 | lung: | n/a | n/a |
46 | GABPA | chr3:638980-639383 | Hela-S3 | cervix: | n/a | n/a |
47 | GATA2 | chr3:621236-621544 | SH-SY5Y | brain: | n/a | chr3:621342-621349 chr3:621342-621353 chr3:621342-621349 chr3:621335-621356 chr3:621337-621353 chr3:621342-621349 |
48 | GATA3 | chr3:630942-631047 | SH-SY5Y | brain: | n/a | n/a |
49 | GATA3 | chr3:620053-620583 | SH-SY5Y | brain: | n/a | chr3:620504-620525 |
50 | GATA3 | chr3:636965-637085 | SH-SY5Y | brain: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IL5RA-14 | chr3:659472-659997 | NONHSAT087571 |
2 | lnc-CHL1-3 | chr3:633788-633866 | ENSG00000224957 |
3 | lnc-CHL1-3 | chr3:633788-633866 | NR_110118 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238075 | TF binding region |
DCBLD2 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545695081 | chr3:611985-611986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560503947 | chr3:612010-612011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116245793 | chr3:612031-612032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9862617 | chr3:612055-612056 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs548117325 | chr3:612082-612083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184722949 | chr3:612099-612100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531546006 | chr3:612110-612111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75462368 | chr3:612152-612153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs578199213 | chr3:612176-612177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189439134 | chr3:612181-612182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547274861 | chr3:612184-612185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539546283 | chr3:612203-612204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9867540 | chr3:612215-612216 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs111363618 | chr3:612222-612223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142907564 | chr3:612267-612268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4684486 | chr3:612268-612269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7645799 | chr3:612269-612270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2729148 | chr3:612273-612274 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs556506772 | chr3:612283-612284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533831281 | chr3:612285-612286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112207968 | chr3:612287-612288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35127358 | chr3:612291-612292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558683518 | chr3:612292-612293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545728122 | chr3:612318-612319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560737611 | chr3:612347-612348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs79149229 | chr3:612348-612349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs151066934 | chr3:612361-612362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs80095906 | chr3:612368-612369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35322394 | chr3:612374-612375 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs561327011 | chr3:612380-612381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2930517 | chr3:612388-612389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531761900 | chr3:612396-612397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550229814 | chr3:612399-612400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189227490 | chr3:612614-612615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs57220106 | chr3:612620-612621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571887890 | chr3:612632-612633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539186718 | chr3:612642-612643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181023038 | chr3:612649-612650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2955649 | chr3:612677-612678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2930515 | chr3:612683-612684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572819462 | chr3:612714-612715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543304068 | chr3:612750-612751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554696147 | chr3:612772-612773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576371857 | chr3:612773-612774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186842091 | chr3:612793-612794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2729211 | chr3:633816-633817 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs559342256 | chr3:633819-633820 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs146518297 | chr3:633829-633830 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs5846012 | chr3:633849-633850 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs145631971 | chr3:636403-636404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Lung cancer | 16618734 | CNVD |
Autism | 18349135 | CNVD |
Breast cancer | 20409316 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Intellectual disability | 22045946 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Mental retardation | 17124404 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 22543975 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 20685689 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:611200-612400 | Weak transcription | Fetal Brain Male | brain |
2 | chr3:612600-612800 | Enhancers | Fetal Brain Male | brain |
3 | chr3:636400-642600 | Enhancers | Hela-S3 | cervix |
4 | chr3:639200-639800 | Enhancers | Dnd41 | blood |
5 | chr3:649000-650000 | Enhancers | Hela-S3 | cervix |
6 | chr3:649200-650200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:659600-660000 | Active TSS | Spleen | Spleen |
8 | chr3:663600-664000 | Enhancers | Fetal Brain Male | brain |